Strides Pharma Science Share Price
Small Cap | Pharmaceuticals and health care | NSE: STAR | BSE: 532531
₹623.15 -76.00 (-10.87 %)
Last Updated: 04 Apr 2025 03:59 PM
Overview
Open (₹) 699.15
High (₹) 716.80
Low (₹) 606.15
Prev. Close (₹) 699.15
Volume 13,06,060
VWAP (₹) 616.80
ROCE (%) 18.99
Industry P/E 44.73
TTM P/E 21.30
P/B Ratio 2.76
Market Cap (₹) Cr.5,743.12
Dividend Yield (%)0.40
EPS (₹) -7.76
ROE-3.44%
Sales Growth (%) 9.83
Profit Growth (%)11.61
Day Range
716.80716.80
52 Week Range
530.701,675.25
Historical Returns
Returns (6M)
-55.81 %
Returns (1Y)
-26.38 %
Returns (3Y)
65.25 %
Returns (5Y)
96.08 %
Returns (6M)
-55.81 %
Returns (1Y)
-26.38 %
Returns (3Y)
65.25 %
Returns (5Y)
96.08 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
- Increasing Annual Revenue for Past 2 Years
- Growth in Net Profit Margin (QoQ)
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
RSI 34.30
MFI 27.97
ATR 41.29
Commodity Channel Index -89.79
ROC125 -52.56
ROC21 -5.94
Williams %R -71.00
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 636.75 | 654.00 | 669.25 | 621.50 | 604.25 | 589.00 | 571.75 |
Week Ago | 669.40 | 686.90 | 714.10 | 642.20 | 624.70 | 597.50 | 580.00 |
Month Ago | 598.10 | 623.45 | 656.90 | 564.65 | 539.30 | 505.85 | 480.50 |
EMA & SMA
623.15
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 643.15
9 Day 631.85
10 Day 637.49
12 Day 652.03
14 Day 662.86
20 Day 669.27
26 Day 653.19
50 Day 659.51
100 Day 1042.09
200 Day 1058.24
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
AUTHUM INVESTMENT & INFRASTRUCTURE LIMITED | bulk | Buy | 22 Jan, 2025 | ₹558.88 | 5,18,350 | NSE |
SOCIETE GENERALE | block | Sell | 25 Jan, 2024 | ₹671.85 | 1,99,486 | NSE |
MARSHALL WACE INVESTMENT STRATEGIES EUREKA FUND | block | Buy | 25 Jan, 2024 | ₹671.85 | 1,99,486 | NSE |
AMANSA HOLDING PRIVATE LTD. | bulk | Buy | 02 Jan, 2024 | ₹659.41 | 5,94,000 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 11 Dec, 2023 | ₹546.00 | 5,75,276 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 11 Dec, 2023 | ₹546.26 | 5,75,276 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 15 Sept, 2023 | ₹506.80 | 8,75,143 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 15 Sept, 2023 | ₹506.98 | 8,75,143 | NSE |
SHASUN ENTERPRISES LLP | block | Sell | 28 Aug, 2023 | ₹438.00 | 2,30,000 | NSE |
MORGAN STANLEY ASIA (SINGAPORE) PTE. - ODI | block | Buy | 28 Aug, 2023 | ₹438.00 | 2,30,000 | NSE |
CAPRI GLOBAL HOLDINGS PRIVATE LIMITED | bulk | Sell | 22 Mar, 2022 | ₹349.05 | 5,50,000 | NSE |
CAPRI GLOBAL ADVISORY SERVICES PRIVATE LIMITED | bulk | Buy | 22 Mar, 2022 | ₹349.24 | 5,50,000 | NSE |
BASUKINATH PROPERTIES PVT LTD | bulk | Sell | 10 Dec, 2021 | ₹461.33 | 6,81,167 | NSE |
BASUKINATH PROPERTIES PVT LTD | bulk | Buy | 10 Dec, 2021 | ₹460.29 | 6,81,167 | NSE |
CHAYADEEP PROPERTIES PVT. LTD. | block | Sell | 04 Nov, 2020 | ₹653.55 | 4,11,060 | NSE |
PRONOMZ VENTURES LLP | block | Buy | 04 Nov, 2020 | ₹653.55 | 4,11,060 | NSE |
SHANKARLAL DEVENDRA | block | Sell | 11 Sept, 2020 | ₹665.40 | 6,00,000 | NSE |
KARUNA BUSINESS SOLUTIONS LLP | block | Buy | 11 Sept, 2020 | ₹665.40 | 6,00,000 | NSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
25 Mar, 2022 | PRONOMZ VENTURES LLP | Acquisition | ₹350.68 | 45,450 | NSE |
24 Mar, 2022 | PRONOMZ VENTURES LLP | Acquisition | ₹330.08 | 53,200 | NSE |
17 Mar, 2022 | AGRAGANYA PRIVATE TRUST | Acquisition | ₹323.42 | 3,00,000 | NSE |
15 Mar, 2022 | PRONOMZ VENTURES LLP | Acquisition | ₹320.79 | 2,91,250 | NSE |
04 Mar, 2022 | PRONOMZ VENTURES LLP | Acquisition | ₹318.02 | 52,000 | NSE |
28 Feb, 2022 | Karuna Business Solutions LLP | Acquisition | ₹327.31 | 1,550 | NSE |
28 Feb, 2022 | Arun Kumar | Acquisition | ₹321.59 | 1,55,200 | NSE |
28 Sept, 2021 | Amit Kumar Himmatsinghka | Disposal | ₹639.76 | 2,600 | NSE |
24 Sept, 2021 | Sandeep Baid | Disposal | ₹628.85 | 4,000 | NSE |
22 Sept, 2021 | Aravinda R | Disposal | ₹602.30 | 2,500 | NSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
22 May, 2024 | Rs.2.5000 per share(25%)Final Dividend | 09 Sept, 2024 | 09 Sept, 2024 |
21 Jul, 2023 | Rs.1.5000 per share(15%)Final Dividend | 04 Aug, 2023 | 04 Aug, 2023 |
27 May, 2021 | Rs.2.5000 per share(25%)Final Dividend | 05 Aug, 2021 | 06 Aug, 2021 |
Announcements
Date | Source | Detail |
---|---|---|
03 Apr, 2025 | NSE India | Intimation for change in details of Key Managerial Personnel for determining materiality of events or information and making disclosure to Stock Exchanges under Regulation 30 of SEBI Listing Regulations effective April 5, 2025 |
03 Apr, 2025 | BSE India | Intimation for change in details of Key Managerial Personnel for determining materiality of events or information and making disclosure to Stock Exchanges under Regulation 30 of SEBI Listing Regulations effective April 5, 2025 |
01 Apr, 2025 | NSE India | Strides Pharma Science Limited has informed the Exchange about Update on redemption of Secured, Unlisted, Redeemable, Non-Convertible Debentures |
01 Apr, 2025 | BSE India | Redemption of balance outstanding NCDs of Rs. 24.20 Crores. |
24 Mar, 2025 | NSE India | STRIDES PHARMA SCIENCE LIMITED has informed the Exchange about Closure of Trading Window |
21 Mar, 2025 | NSE India | Strides Pharma Science Limited has submitted the Exchange a copy Srutinizers report and voting results in respect of Postal Ballot process. |
21 Mar, 2025 | BSE India | Results and Scrutinizers report in respect of Postal ballot |
21 Mar, 2025 | BSE India | Results along with Scrutinizers report for Postal Ballot process. |
19 Mar, 2025 | NSE India | Strides Pharma Science Limited has informed the Exchange regarding Update-Acquisition/Scheme/Sale/Disposal-XBRL |
19 Mar, 2025 | NSE India | Strides Pharma Science Limited has informed the Exchange about Update regarding intimation of March 14, 2025 relating to Amexel. |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 25 Jan, 2025 | 30 Jan, 2025 |
Quarterly Results | -- | 21 Oct, 2024 | 24 Oct, 2024 |
Quarterly Results | -- | 23 Jul, 2024 | 29 Jul, 2024 |
Audited Results & Final Dividend | -- | 15 May, 2024 | 22 May, 2024 |
Quarterly Results | -- | 24 Jan, 2024 | 30 Jan, 2024 |
Quarterly Results | -- | 23 Oct, 2023 | 30 Oct, 2023 |
Scheme of Arrangement | -- | 21 Sept, 2023 | 25 Sept, 2023 |
Quarterly Results | -- | 27 Jul, 2023 | 02 Aug, 2023 |
Audited Results & Final Dividend | -- | 19 May, 2023 | 25 May, 2023 |
Quarterly Results | -- | 18 Jan, 2023 | 24 Jan, 2023 |
Share Holding Pattern
- Promoter
- FII
- DII
- Public
Owner Name | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
---|---|---|---|---|---|
Promoter Group | 26.82% | 27.39% | 30.89% | 29.6% | 29.69% |
Foreign Institutions + | 28.48% | 19.45% | 18.98% | 19.85% | 25.16% |
Domestic Institutions + | 16.92% | 19.41% | 18.84% | 21.07% | 16.65% |
Government | 0.01% | 0.01% | 0.01% | 0% | 0% |
Public | 27.77% | 33.74% | 31.28% | 29.48% | 28.5% |
Others | 0% | 0% | 0% | 0% | 0% |
About Strides Pharma Science
Strides Pharma Science is a Public Limited Listed company incorporated on 28/06/1990 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1990PLC057062 and registration number is 057062. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 2153.26 Cr. and Equity Capital is Rs. 91.90 Cr. for the Year ended 31/03/2024.
Parent Organisation
Strides Group
Founded
1990
Managing Director
Mr. Badree Komandur
NSE Symbol
STAR
Strides Pharma Science Management
Name | Designation |
---|---|
Mr. Arun Kumar | Executive Chairperson |
Mr. Badree Komandur | Managing Director & Group CEO |
Mr. Aditya Kumar | Executive Director |
Dr. Kausalya Santhanam | Independent Director |
Mr. Homi Rustam Khusrokhan | Independent Director |
Mr. Ameet Hariani | Independent Director |
Mr. Subir Chakraborty | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Sun Pharmaceutical Industries | ₹4,10,130.32 | ₹1,709.35 ₹1,770.00(-3.43%) | ₹1,376.750 - ₹1,960.200 |
Divi's Laboratories | ₹1,45,552.44 | ₹5,482.85 ₹5,763.00(-4.86%) | ₹3,613.550 - ₹6,448.750 |
Cipla | ₹1,14,298.01 | ₹1,415.25 ₹1,495.70(-5.38%) | ₹1,317.600 - ₹1,702.000 |
Torrent Pharmaceuticals | ₹1,11,230.09 | ₹3,286.50 ₹3,247.70(1.19%) | ₹2,508.650 - ₹3,589.950 |
Mankind Pharma | ₹1,01,131.25 | ₹2,451.20 ₹2,427.70(0.97%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Strides Pharma Science
What is the share price of Strides Pharma Science?
The share price of Strides Pharma Science on 04 Apr, 2025 is ₹ 623.15.
What is 52W high and 52W low share price of Strides Pharma Science?
The highest and lowest 52W share prices of Strides Pharma Science are ₹ 1675.250 and ₹ 530.700
What is the market cap of Strides Pharma Science?
The market capitalization of Strides Pharma Science as of 04 Apr, 2025 is ₹ 5,743.12 Crores
What is the P/E ratio of Strides Pharma Science?
The current P/E ratio of Strides Pharma Science as of 04 Apr, 2025 is 44.73
What is the PB ratio of Strides Pharma Science?
The PB ratio of Strides Pharma Science as of 04 Apr, 2025 is 2.76
Top Gainers
₹18.07
₹15.14 (0.19%)
₹66.60
₹57.80 (0.15%)
₹88.74
₹73.95 (0.20%)
₹197.50
₹167.35 (0.18%)
Top Losers
₹307.35
₹368.55 (-0.17%)
₹108.20
₹127.00 (-0.15%)
₹0.54
₹1.03 (-0.48%)
₹2,705.55
₹3,206.90 (-0.16%)
Market Indices
Sensex
₹75,364.69
₹76,295.36 (-0.01%)